- Home
- PR vs MEDP Comparison
PR vs MEDP Comparison
Compare PR & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PR
- MEDP
- Stock Information
- Founded
- PR 2015
- MEDP 1992
- Country
- PR United States
- MEDP United States
- Employees
- PR N/A
- MEDP N/A
- Industry
- PR Oil & Gas Production
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PR Energy
- MEDP Health Care
- Exchange
- PR Nasdaq
- MEDP Nasdaq
- Market Cap
- PR 9.6B
- MEDP 8.5B
- IPO Year
- PR 2016
- MEDP 2016
- Fundamental
- Price
- PR $14.17
- MEDP $320.95
- Analyst Decision
- PR Strong Buy
- MEDP Hold
- Analyst Count
- PR 15
- MEDP 11
- Target Price
- PR $18.29
- MEDP $338.90
- AVG Volume (30 Days)
- PR 13.2M
- MEDP 408.6K
- Earning Date
- PR 08-05-2025
- MEDP 07-21-2025
- Dividend Yield
- PR 4.22%
- MEDP N/A
- EPS Growth
- PR 39.99
- MEDP 33.36
- EPS
- PR 1.62
- MEDP 13.09
- Revenue
- PR $5,134,186,000.00
- MEDP $2,156,580,000.00
- Revenue This Year
- PR $7.10
- MEDP $5.64
- Revenue Next Year
- PR $1.46
- MEDP $3.32
- P/E Ratio
- PR $8.76
- MEDP $24.64
- Revenue Growth
- PR 37.00
- MEDP 9.87
- 52 Week Low
- PR $10.01
- MEDP $250.05
- 52 Week High
- PR $16.95
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- PR 54.44
- MEDP 58.64
- Support Level
- PR $13.60
- MEDP $315.88
- Resistance Level
- PR $14.64
- MEDP $325.43
- Average True Range (ATR)
- PR 0.46
- MEDP 8.47
- MACD
- PR -0.04
- MEDP 1.18
- Stochastic Oscillator
- PR 49.68
- MEDP 75.78
About PR Permian Resources Corporation
Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.